Swiss HealthTech startup Aeon, based in Zurich, has raised €8.2 million in a Seed round to further develop its AI preventive health platform.
The funding round was led by Concentric and included investors like Calm/Storm Ventures, GoHub Ventures, Kadmos Capital, EWOR, and Swiss super angel investor Daniel Gutenberg.
Aeon offers AI-powered check-ups incorporating whole-body MRI, blood biomarker analysis, and genetic testing to provide early detection and prediction of over 500 diseases and health risks.
The company plans to expand across Switzerland, Germany, and the UK, improve partnerships with insurers and employers, and enhance its AI platform for more precise diagnostics.